OGI
Price
$1.52
Change
-$0.03 (-1.94%)
Updated
Jan 31, 11:34 AM (EDT)
Capitalization
200.85M
SNOA
Price
$2.67
Change
-$0.00 (-0.00%)
Updated
Jan 31, 11:47 AM (EDT)
Capitalization
2.39M
Ad is loading...

OGI vs SNOA

Header iconOGI vs SNOA Comparison
Open Charts OGI vs SNOABanner chart's image
Organigram Holdings
Price$1.52
Change-$0.03 (-1.94%)
Volume$5K
Capitalization200.85M
Sonoma Pharmaceuticals
Price$2.67
Change-$0.00 (-0.00%)
Volume$1.6K
Capitalization2.39M
OGI vs SNOA Comparison Chart
Loading...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGI vs. SNOA commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGI is a Hold and SNOA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (OGI: $1.55 vs. SNOA: $2.66)
Brand notoriety: OGI and SNOA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OGI: 53% vs. SNOA: 82%
Market capitalization -- OGI: $200.85M vs. SNOA: $2.39M
OGI [@Pharmaceuticals: Other] is valued at $200.85M. SNOA’s [@Pharmaceuticals: Other] market capitalization is $2.39M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGI’s FA Score shows that 0 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • OGI’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than OGI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGI’s TA Score shows that 4 TA indicator(s) are bullish while SNOA’s TA Score has 5 bullish TA indicator(s).

  • OGI’s TA Score: 4 bullish, 3 bearish.
  • SNOA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SNOA is a better buy in the short-term than OGI.

Price Growth

OGI (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SNOA (@Pharmaceuticals: Other) price change was +0.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.15%. For the same industry, the average monthly price growth was +2.96%, and the average quarterly price growth was -6.87%.

Reported Earning Dates

OGI is expected to report earnings on Nov 27, 2023.

SNOA is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-2.15% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGI($201M) has a higher market cap than SNOA($2.39M). SNOA YTD gains are higher at: -1.115 vs. OGI (-3.727). SNOA has higher annual earnings (EBITDA): -4.27M vs. OGI (-195.74M). OGI has more cash in the bank: 42.3M vs. SNOA (2.41M). OGI has less debt than SNOA: OGI (136K) vs SNOA (385K). OGI has higher revenues than SNOA: OGI (161M) vs SNOA (12.3M).
OGISNOAOGI / SNOA
Capitalization201M2.39M8,407%
EBITDA-195.74M-4.27M4,584%
Gain YTD-3.727-1.115334%
P/E RatioN/AN/A-
Revenue161M12.3M1,309%
Total Cash42.3M2.41M1,758%
Total Debt136K385K35%
FUNDAMENTALS RATINGS
OGI vs SNOA: Fundamental Ratings
OGI
SNOA
OUTLOOK RATING
1..100
7711
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
9764
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (59) in the null industry is in the same range as SNOA (65) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to SNOA’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as SNOA (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to SNOA’s over the last 12 months.

OGI's SMR Rating (94) in the null industry is in the same range as SNOA (98) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to SNOA’s over the last 12 months.

OGI's Price Growth Rating (61) in the null industry is in the same range as SNOA (64) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to SNOA’s over the last 12 months.

SNOA's P/E Growth Rating (64) in the Pharmaceuticals Other industry is somewhat better than the same rating for OGI (97) in the null industry. This means that SNOA’s stock grew somewhat faster than OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OGISNOA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 29 days ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 29 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBLG1.120.10
+9.80%
Bone Biologics Corp
KGS49.661.61
+3.35%
Kodiak Gas Services
WCC189.392.75
+1.47%
Wesco International
THCH3.140.03
+0.80%
TH International Ltd
PAHC21.980.08
+0.37%
Phibro Animal Health Corp

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with CRON. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then CRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+3.33%
CRON - OGI
67%
Closely correlated
+2.66%
SNDL - OGI
67%
Closely correlated
+4.62%
TLRY - OGI
63%
Loosely correlated
+8.65%
CGC - OGI
57%
Loosely correlated
+3.45%
ACB - OGI
52%
Loosely correlated
+3.24%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
-1.12%
BNXTF - SNOA
29%
Poorly correlated
N/A
BGLAF - SNOA
27%
Poorly correlated
N/A
AKAN - SNOA
25%
Poorly correlated
-3.09%
OGI - SNOA
24%
Poorly correlated
+3.33%
TAK - SNOA
23%
Poorly correlated
+2.93%
More